Pharma General Ontology (PGO) Project – Phase 1

Pharma General Ontology (PGO) Project – Phase 1

When

JavaScript Disabled
JavaScript Disabled
(Date and time are shown in your browser's local time zone)

Event Type

Data inter-operability is a key enabler to accelerate life science workflows. Yet, many concrete hurdles exist. For example, organizations use different definitions for similar core concepts, requiring significant amounts of mappings across data sets even within a given company. The first objective of the Pharma General Ontology (PGO) project is to define a set of agreed-upon core entities, the PGO “core concepts”, and recommendations for associating controlled terminologies to service data exchange among Pharmaceutical Industry stakeholders. By reusing community-agreed terms and definitions, PGO aims to help organizations enhance data interoperability, integration, discovery, and reuse.
 
The webinar will address:

  • PGO vision
  • Deliverables Phase 1 & Next Steps
  • Q&A Session with the participants

 

Speakers
  • Philippe Rocca-Serra / Astrazeneca / Senior Director – FAIR Collaboration – Data Office
  • Martin Romacker / Roche / Product Manager Roche Data Marketplace (RDM)
  • Markus Hartmann / Merck Group / Global Product Lead Data Semantics
  • Birgit Meldal / Pfizer / Senior Manager, Enterprise Data Standards and Ontologies
  • Peter McQuilton / GSK / Senior Product Owner – Reference Data, Information & Data Architecture and Ontologies
  • Elena Businaro / Chiesi Group / R&D and PPM Digital Strategy and Execution Support Head​
  • Joshua Daniel Valdez / Novo Nordisk / Head of Ontology and Semantic Engineering

Moderation: Giovanni Nisato / Pistoia Alliance / Project Manager PGO
 

Register below